Maitake as an Adjunct Treatment for Cancer

Maitake has been used as an adjunctive treatment of cancers (mastocarcinoma, cancer of pancreas, breast, ovarian, skin, liver, lung, prostate and gastric cancer) providing efficiency in killing human cancer cells, suppressing tumor growth, and increasing the number of cells fighting against the tumor. We focus on the word "adjunctive" meaning an added supplement to various cancer treatments rather than an essential part. Mógū Mushrooms does not recommend avoiding cancer treatments advised by your doctor such as chemotherapy and radiotherapy.

Mushroom supplements are often used as a potent immunomodulatory action taken together with these harsh cancer treatments. Clinical studies and research show direct correlation in reducing the side effects of chemotherapy and radiotherapy.

Clinical Study: A non-randomized clinical study using D-fraction and raw Maitake tablets was conducted to investigate its effectiveness against cancer patients as they were against animals. The study was carried out with 165 patients with advanced cancer, stage III-IV, 25-65 years old. Most of the patients receiving the Maitake treatment claimed improvement of overall symptoms. The highest response rates were seen with breast, lung, and liver cancer patients. If taken with chemotherapy, these response rates improved by 12-28%. In several cases with both liver and lung cancer, the patients went from dangerous stage III status to more manageable stages. Among those receiving chemotherapy, side effects were ameliorated in 90% of cases, and in virtually all cases, there was improved quality of life. (1)

Clinical Study: Another 2013 study indicates that maitake D-Fraction could be useful in preventing and treating breast cancer. Researchers suggesting that this mushroom can fight the growth and reproduction of cancerous cells. (2)

References:

1. (Nanba H., Results of non-controlled clinical study for various cancer patients using Maitake D-Fraction, Explore! Professionals, 6, 1995)

2. (Eliana Noelia Alonso, Manuela Orozco, Alvaro Eloy Nieto, and Gabriela Andrea Balogh. Genes Related to Suppression of Malignant Phenotype Induced by Maitake D-Fraction in Breast Cancer Cells. Journal of Medicinal FoodVolume: 16 Issue 7: July 22, 2013)

Drop us a line

Have a question?

Link to some useful pages that your customers might want to know about.

Returns & ExchangesGeneral QuestionsReturns & ExchangesShipping Policies.